Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Felipe Falla

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Surgical Oncology|March 2, 2026
Patient-Reported Financial Toxicity of Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyVladislav Kovalik, Armando Sardi, Luis Felipe Falla-Zuniga, et al.
Gynecologic Oncology Reports|March 17, 2025
Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySergei Iugai, Armando Sardi, Teresa Diaz-Montes, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 17, 2023
Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcomaFelipe Lopez-Ramirez, Armando Sardi, Kimberley Studeman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2025
Prognostic value of preoperative serum C-reactive protein level for survival in mucinous appendix cancer treated with complete CRS/HIPECAndrei Nikiforchin, Armando Sardi, Mary Caitlin King, et al.
Annals of Surgical Oncology|August 26, 2023
Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal ChemotherapyAndrei Nikiforchin, Armando Sardi, Mary Caitlin King, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 25, 2026
Clinical characteristics and outcomes of patients with goblet cell adenocarcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC): A multicenter cohort studySergei Iugai, Vadim Gushchin, Mary Caitlin King, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 6, 2024
Collaborative expertise of gynecological and surgical oncologists in managing advanced epithelial ovarian cancerAndrei Nikiforchin, Armando Sardi, Mary Caitlin King, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Surgical Oncology|March 2, 2026
Patient-Reported Financial Toxicity of Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyVladislav Kovalik, Armando Sardi, Luis Felipe Falla-Zuniga, et al.
Gynecologic Oncology Reports|March 17, 2025
Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySergei Iugai, Armando Sardi, Teresa Diaz-Montes, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 17, 2023
Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcomaFelipe Lopez-Ramirez, Armando Sardi, Kimberley Studeman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2025
Prognostic value of preoperative serum C-reactive protein level for survival in mucinous appendix cancer treated with complete CRS/HIPECAndrei Nikiforchin, Armando Sardi, Mary Caitlin King, et al.
Annals of Surgical Oncology|August 26, 2023
Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal ChemotherapyAndrei Nikiforchin, Armando Sardi, Mary Caitlin King, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 25, 2026
Clinical characteristics and outcomes of patients with goblet cell adenocarcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC): A multicenter cohort studySergei Iugai, Vadim Gushchin, Mary Caitlin King, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 6, 2024
Collaborative expertise of gynecological and surgical oncologists in managing advanced epithelial ovarian cancerAndrei Nikiforchin, Armando Sardi, Mary Caitlin King, et al.
Pageof 2